adresse: Tokyo, Japon

thérapie par cellules souches en Espagne Barcelone WhatsApp: +447778936902 , +33745637397, +34670491885

Medical institutions that provide regenerative medicine using stem cells
create a regenerative medicine provision plan for each regenerative medicine technology they implement, et faites-le examiner pour des raisons de sécurité, efficacité, etc..
by a specified certified regenerative medicine committee approved by the Ministry of Health, Labor and Welfare receive.


Aging care (intravenous therapy/injection)
Various stem cell treatments such as anti-aging prevention


All of our staff members are committed to working closely with you and providing medical care to the best of our ability. We look forward to serving you, with the promise of advanced workmanship and high-quality hospitality.

皆様に寄り添いスタッフ一同 全力で診療にあたる所存でございます

Potential of mesenchymal stem cells
There are approximately 60 trillion cells in our body. Our tissues, such as the heart, cerveau, and skin, are made up of cells that play an extremely important role in our daily lives. There are approximately 270 types of cells depending on their role. The cells that form the basis of these cells are « stem cells. » Stem cells are cells that transform into various cells and tissues and exist in fixed locations in the body. These cells produce cells to replace tissue when it is damaged.

It has long been known that these stem cells exist in the bone marrow. Cependant, there is a limit to the amount of stem cells that can be harvested from bone marrow, and harvesting requires general anesthesia, which is a burdensome operation for patients. Dans 2000, Docteur. Hedrick of UCLA (University of California, Les anges) discovered that abdominal subcutaneous fat contains a large amount of stem cells. Various studies have been conducted on the basic characteristics of adipose-derived mesenchymal stem cells. Adipose-derived mesenchymal stem cells, which are easy to collect, highly safe, and have a wide range of efficacy, are attracting attention as cells that are key to regenerative medicine.

En outre, le « Act on Ensuring the Safety of Regenerative Medicine, etc.. (Act No. 85 de 2013) » was enacted on November 25, 2014, and clinical research (clinical research using human stem cells, etc.) is free. Rules to be respected by medical institutions and cell processing product manufacturers have been established so that research, développement, and practical application of high-quality regenerative medicine can proceed safely in medical practice, and in order to provide regenerative medicine quickly and safely. The environment is now in place.


この幹細胞は以前から骨髄に存在する事が知られていましたしかし骨髄から採取できる幹細胞には限りがあり採取する際は全身麻酔が必要になるなど患者様に負担のかかる手術が必要でした。2000年にUCLA(カリフォルニア 大学ロサンゼルス校)のDr.Hedrickが腹部皮下脂肪に大量の幹細胞が含まれている事を発見しました脂肪由来間葉 系幹細胞の基本的な特性については様々な研究が積み重ねられています採取が容易で安全性が高くその有効性が多岐にわたる脂肪由来間葉系幹細胞は再生医療の鍵となる細胞として注目を集めています


 thérapie par cellules souches en Espagne Barcelone WhatsApp: +447778936902 , +33745637397, +34670491885



organisme de recherche sous contrat

thérapie par cellules souches